Lillia Nets US$1.7 Million Grant From Qatar’s QRDI Council
Founded by Sujit Chakrabarty in 2020, the Qatar-based startup specializes in AI-powered chronic disease management and has launched a platform to support individuals with diabetes and related conditions.
Qatar-based artificial intelligence (AI)-driven healthtech startup Lillia has received a US$1.7 million grant from the Qatar Research, Development and Innovation (QRDI) Council to develop the first digital twin in the GCC focused on chronic conditions.
Founded by Sujit Chakrabarty in 2020, the company specializes in AI-powered chronic disease management and has launched a platform to support individuals with diabetes and related conditions.
By combining AI with expert human coaches, including psychologists, nutritionists, and doctors, Lillia tailors care plans to users’ metabolism and lifestyle, promoting long-term healthy habits with proven clinical results.
“Diabetes and related chronic conditions are the world’s biggest healthcare challenge, affecting more than 500 million people," Chakrabarty, Lillia’s founder and CEO, said in a statement. "The good news is with the right interventions, diabetes can be prevented and reversed in the early stages or effectively managed for long-term health. Lillia exists to lower the chronic disease burden for the world by providing continuous adaptive care that drives a real and lasting lifestyle change.”
Nada Al-Olaqi, director of innovation development and piloting programs at QRDI Council, commented, “At QRDI Council, we’re proud to support Lillia as they push the boundaries of healthcare innovation with their AI-driven digital twin technology. Through our Technology Development Grant program, we empower pioneering companies like Lillia to bring transformative technology solutions to life, advancing healthcare, enhancing quality of life, and positioning Qatar as a leader in digital transformation. This partnership reinforces our shared commitment to creating a lasting impact for communities both locally and globally.”
Backed by investors including Qatar Development Bank, Qatar Science and Technology Park, and M Venture Partners, Lillia was formed through the 2024 merger of Qatar-based Droobi Health LLC and India-based Smit.fit. It has since gone on to support over 40,000 individuals in managing diabetes and weight-related conditions across the GCC and India.
Lillia also boasts of partnerships with 20 institutional clients in the healthcare, corporate, insurance, and public sectors, reporting clinical improvements for up to 80 percent of enrolled patients.
During this year's edition of Web Summit Qatar, Lillia introduced its vision for a chronic care digital twin paired with AI agents to enhance predictive capabilities, including real-time risk monitoring and precision medication.
Lillia plans to expand its services across the MENA and Southeast Asia regions over the next two years as it advances AI-led chronic disease management on a global scale.
Pictured on image is Sujit Chakrabarty, founder and CEO, Lillia. Image courtesy Lillia.
